Recent research demonstrate the efficacy of RMP1-14, a specifically developed anti-mouse PD-1 therapeutic, for improving tumor immune response . Unlike current approaches, RMP1-14 exhibits enhanced https://socialmediainuk.com/story27989137/utilizing-this-a-novel-murine-pd-1-agent-for-immunotherapy